Impact of duration of neoadjuvant therapy on pathologic and clinical outcomes for pancreatic adenocarcinoma

被引：0
|
作者：
Galouzis, Nicholas [1 ]
Khawam, Maria [1 ]
Khreiss, Mohammad R. [1 ]
Mesropyan, Lusine [1 ]
Riall, Taylor S. [1 ]
Luu, Carrie [1 ]
机构：
[1] Univ Arizona, Tucson, AZ USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E260
引用
收藏
页码：S192 / S193
页数：2
相关论文
共 50 条
  • [1] Outcomes of Neoadjuvant Radiation Therapy for Resectable Pancreatic Adenocarcinoma
    Tee, M. C.
    Chen, L.
    Segedi, M.
    Ferrel, B.
    Kim, P.
    Chartier-Plante, S.
    Chung, S.
    Franko, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S83 - S83
  • [2] Pathologic complete response following neoadjuvant therapy for pancreatic ductal adenocarcinoma: defining the incidence, predictors, and outcomes
    Cloyd, Jordan M.
    Ejaz, Aslam
    Shen, Chengli
    Dillhoff, Mary
    Williams, Terence M.
    Noonan, Anne
    Pawlik, Timothy M.
    Tsung, Allan
    [J]. HPB, 2020, 22 (11) : 1569 - 1576
  • [3] Impact of care fragmentation on the outcomes of patients receiving neoadjuvant and adjuvant therapy for pancreatic adenocarcinoma
    Brown, Zachary J.
    Labiner, Hanna E.
    Shen, Chengli
    Ejaz, Aslam
    Pawlik, Timothy M.
    Cloyd, Jordan M.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (02) : 185 - 193
  • [4] Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response
    Barrak, Dany
    Villano, Anthony M.
    Villafane-Ferriol, Nicole
    Stockton, Leah G.
    Hill, Maureen, V
    Deng, Mengying
    Handorf, Elizabeth A.
    Reddy, Sanjay S.
    [J]. EJSO, 2022, 48 (06): : 1356 - 1361
  • [5] Total Neoadjuvant Therapy Offers Improved Survival and Pathologic Response in Pancreatic Adenocarcinoma
    O'Halloran, E. A.
    Lefton, M.
    Rhodes, L.
    Hoffman, J.
    Cukierman, E.
    Reddy, S.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S22 - S22
  • [6] Does Pathologic Response after Neoadjuvant Chemoradiation Therapy Have an Impact on Overall Survival in Patients with Pancreatic Adenocarcinoma
    Lin, C.
    Lanzenby, A. J.
    Wang, Z.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E240 - E240
  • [7] THE IMPACT OF NEOADJUVANT THERAPY ON VASCULAR RESECTION IN PANCREATIC DUCTAL ADENOCARCINOMA
    Crocker, Andrew B.
    Barrak, Dany
    Hopkins, Steven E.
    Egleston, Brian
    Reddy, Sanjay S.
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1556 - S1556
  • [8] Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
    Vidri, Roberto J.
    Varley, Patrick R.
    Ronnekleiv-Kelly, Sean M.
    Kaitlyn, Kelly J.
    Wilson, Gregory C.
    Ahmad, Syed
    Snyder, Rebecca A.
    Parikh, Alexander A.
    Hammill, Chet W.
    Kim, Hong Jin
    LeCompte, Michael T.
    Kooby, David A.
    Shah, Mihir M.
    Maithel, Shishir K.
    Merchant, Nipun B.
    Datta, Jashodeep
    Zafar, Syed Nabeel
    Weber, Sharon M.
    Abbott, Daniel E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S42 - S42
  • [9] Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma
    Villano, Anthony M.
    O'Halloran, Eileen
    Goel, Neha
    Ruth, Karen
    Barrak, Dany
    Lefton, Max
    Reddy, Sanjay S.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2022, 126 (03) : 502 - 512
  • [10] Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
    Sell, Naomi M.
    Lee, Grace C.
    Fernandez-Del Castillo, Carlos
    Ferrone, Cristina R.
    Warshaw, Andrew L.
    Hong, Theodore S.
    Blaszkowsky, Lawrence S.
    Lillemoe, Keith D.
    Qadan, Motaz
    [J]. PANCREAS, 2020, 49 (07) : 897 - 903
12345